Perrigo Company PLC (NYSE:PRGO)
| 30.90 Delayed Data As of Dec 01 |  +0.44 / +1.44%Today’s Change | 26.81 Today|||52-Week Range 40.28 | -9.36% Year-to-Date |
PRGO Regular Dividend: PRGO began trading ex-dividend on 11/30/23. A $0.273 dividend will be paid to shareholders of record as of 12/01/23.
Latest PRGO News | Press Releases
| Insider Buying Alert: EVP & CHRO Robert Willis Acquires Shares of Perrigo Co PLC Nov 28 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 30.46 |
| Today’s open | 30.35 |
| Day’s range | 30.34 - 30.98 |
| Volume | 1,346,462 |
| Average volume (3 months) | 1,512,318 |
| Market cap | $4.2B |
Data as of 4:00pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -19.98% |
| Earnings growth (this year) | +26.57% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | +7.47% |
| P/E ratio | 386.3 |
| Price/Sales | 1.03 |
| Price/Book | 0.86 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALKSAlkermes Plc | +0.15 | +0.62% |
| MDGLMadrigal Pharmaceuti... | +9.76 | +4.80% |
| MRTXMirati Therapeutics ... | +0.35 | +0.62% |
| ---- |
Data as of 4:00pm ET, 12/01/2023
Financials
| Next reporting date | February 29, 2024 |
| EPS forecast (this quarter) | $0.93 |
| Annual revenue (last year) | $4.5B |
| Annual profit (last year) | -$140.6M |
| Net profit margin | -2.94% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
